Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders

06-06-2017 дата публикации

Номер:

US9669035B2

Автор: Antonius Adrianus Hendrikus Petrus Megens, José Ignacio Andrés-Gil, Xavier Jean Michel Langlois

Принадлежит: Janssen Pharmaceutica NV

Контакты:

Номер заявки:

Дата заявки:

CPC - классификация

A A6 A61 A61K A61K2 A61K23 A61K230 A61K2300 A61K2300/A61K2300/0 A61K2300/00 A61K3 A61K31 A61K31/A61K31/4 A61K31/47 A61K31/470 A61K31/4709 A61K31/472 A61K31/4725 A61K31/5 A61K31/51 A61K31/517 A61K31/53 A61K31/537 A61K31/5377 A61K4 A61K45 A61K45/A61K45/0 A61K45/06 A61K49 A61K49/A61K49/0 A61K49/06 A61P A61P2 A61P21 A61P21/A61P21/0 A61P21/00 A61P25 A61P25/A61P25/0 A61P25/00 A61P25/04 A61P25/1 A61P25/18 A61P25/2 A61P25/22 A61P25/28 A61P25/3 A61P25/36 A61P3 A61P3/A61P3/0 A61P3/00 A61P4 A61P43 A61P43/A61P43/0 A61P43/00 A61P5 A61P5/A61P5/0 A61P5/00

IPC - классификация

A A6 A61 A61P A61P2 A61P21 A61P21/A61P21/0 A61P21/00 A61P25 A61P25/A61P25/0 A61P25/00 A61P25/1 A61P25/18

Получить PDF